Established in 2012, OncoArendi Therapeutics aims to discover and develop drugs for pulmonary diseases, and is one of the three companies in Poland which have successfully completed phase I of clinical trials for a new drug candidate. To find out more about Polish biotech, Michał Owczarek spoke to OncoArendi Therapeutics CEO Marcin Szumowski.